MyHealthyPregnancy mobile health app: Combining behavioral science and machine learning for risk communication during the peripartum period
Project Number2R44DP006417-02
Contact PI/Project LeaderCASTILLO, ANABEL F
Awardee OrganizationNAIMA HEALTH, LLC
Description
Abstract Text
Project Summary/Abstract
Problem: Depression during pregnancy affects approximately 10% of women and is related to low
birthweight and preterm birth. Similarly, up to 9% of pregnant women experience intimate partner violence
(IPV) and abuse, with over 41% of assaults resulting in physical injury, and almost 30% requiring medical
treatment. When untreated, these risks cost health systems at least $50B/year. Mitigation has proven
difficult, where women are reluctant to disclose during clinical visits, and clinicians are unaware of
resources. There are no integrated health technologies that enable timely disclosure of risks during
pregnancy then aid in making decisions about risk mitigation. Fortunately, most women of reproductive
age own a smartphone, and users report comfort disclosing health information to smartphones under the
right conditions.
Naima Health’s Proposed Solution: Naima Health is developing a digital health platform that pairs our
MyHealthyPregnancy (MHP) smartphone application with an EPIC-integrated provider portal to (i)
identify risks early in pregnancy, (ii) communicate those risks to women and their providers, and (iii) assist
decision-making about risk mitigation. MHP identifies risk using ACOG-approved screenings, then helps
patients and providers make real-time decisions about mitigation. The proposed solution aligns with the
CDC’s priority of developing mobile app-based decision support systems for mental health and IPV
screening, assessment, and referral.
Proposed SBIR Work: In Phase I we developed expert and machine learning models to identify risks
during pregnancy, then characterized issues facing Spanish-speaking women. In Phase II we extend these
Phase I results using semi-structured interviews with patients and providers to understand site-specific
requirements for psychosocial risk screening and referral, then update the MHP platform to meet those
requirements (Aim 1). We then validate the updated platform’s performance using qualitative cognitive
testing with patients and providers to ensure the platform meets site-specific requirements (Aim 2). Finally,
we evaluate the platform’s acceptability and feasibility at two collaborating clinic sites, focusing on the rate
of depression and IPV detected through the platform compared to historical rates, and the prevalence of
risk mitigation actions measured through patient calls/click-throughs and provider referrals (Aim 3).
Public Health Relevance Statement
Project Narrative
Untreated psychosocial risks during pregnancy, such as depression and intimate partner violence, are
significant adverse health outcomes for both parent and child, costing society more than $50 billion per
year. Digital health tools for patients and providers can promote early identification of those risks to aid
rapid intervention. The MyHealthyPregnancy (MHP) mobile phone application and provider portal
combines decision science, medicine, machine learning, user-centered design, and app development to
identify and mitigate clinical and psychosocial risks during pregnancy.
National Center for Chronic Disease Prev and Health Promo
CFDA Code
262
DUNS Number
081081430
UEI
NTJHVHU3L8L7
Project Start Date
01-September-2020
Project End Date
31-August-2023
Budget Start Date
01-September-2020
Budget End Date
31-August-2021
Project Funding Information for 2020
Total Funding
$497,952
Direct Costs
Indirect Costs
Year
Funding IC
FY Total Cost by IC
2020
Office of Public Health Research
$497,952
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 2R44DP006417-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 2R44DP006417-02
Patents
No Patents information available for 2R44DP006417-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 2R44DP006417-02
Clinical Studies
No Clinical Studies information available for 2R44DP006417-02
News and More
Related News Releases
No news release information available for 2R44DP006417-02
History
No Historical information available for 2R44DP006417-02
Similar Projects
No Similar Projects information available for 2R44DP006417-02